Overview

Research and Development

This project will make use of the resources of the Pharma Valley Project, a regional R&D resource of a medical engineering partnership agreement among the base of a partnership of industry, academia and government under the enhanced framework of the project to promote urban industry, academia and government partnerships (evolving), the Clinical Research Function of Shizuoka Cancer Center and science and technology universities in the Greater Tokyo area. On the basis of needs at the cancer treatment location, it will do research into the genetic analysis that forms the basis of cancer research, as well as doing research aimed at revolutionary technical developments and commercialization in four reciprocally related problems that must be solved in the modern cancer diagnosis and treatment process; specifically, cancer screening, efficient medical imaging, treatment of early cancer and treatment of recurrence and metastasis.

Of the research themes and feasibility studies carried out at "the formation of a Pharma Valley Medical (health care and wellness industry) Cluster by development of cutting edge cancer diagnostic and treatment technologies to answer bedside needs," a task of the project to promote urban industry, academia and government partnerships (evolving), this project will concentrate on four research themes expected to spread overseas with nearly-completed technologies, aiming at "beating cancer," an essential part of the regional vision of the Pharma Valley Project's ultimate objective of "formation of the healthiest, longest-lived prefecture in the world."

themes（Fiscal Year 2012）

"Development and application of an experimental system to analyze centromere dysfunctions that promote cancer"

Assistant professor Tetsuya Hori, Department of Molecular Genetics, National Institute of Genetics

"Development of techniques for the early detection of cancer by blood test"

Toru Mochizuki, Deputy Director and Director of Medical Genetics Shizuoka Cancer Center Research Institute

"Development of an efficient method for producing fully human monoclonal antibodies for clinical application"

Yasuto Akiyama, Chief of Immunotherapy Division, Shizuoka Cancer Center Research Institute

"Establishment of a bio-chip technology for early diagnosis and treatment of cancer"

Tomoko Yoshino, Associate Professor of Bio-Function and Bioprocesses at the Institute of Engineering, Tokyo University of Agriculture and Technology

themes（Fiscal Year 2011）

"Development and application of an experimental system to analyze centromere dysfunctions that promote cancer"

Professor Tatsuro Fukagawa, Department of Molecular Genetics, National Institute of Genetics

"Development of techniques for the early detection of cancer by blood test"

Toru Mochizuki, Deputy Director and Director of Medical Genetics Shizuoka Cancer Center Research Institute

"Development of an efficient method for producing fully human monoclonal antibodies for clinical application"

Yasuto Akiyama, Chief of Immunotherapy Division, Shizuoka Cancer Center Research Institute

"Establishment of a bio-chip technology for early diagnosis and treatment of cancer"

Tomoko Yoshino, Associate Professor of Bio-Function and Bioprocesses at the Institute of Engineering, Tokyo University of Agriculture and Technology

themes（Fiscal Year 2010）

"Development and application of an experimental system to analyze centromere dysfunctions that promote cancer"

Professor Tatsuro Fukagawa, Department of Molecular Genetics, National Institute of Genetics

"Development of techniques for the early detection of cancer by blood test"

Toru Mochizuki, Deputy Director and Director of Medical Genetics Shizuoka Cancer Center Research Institute

"Development of an efficient method for producing fully human monoclonal antibodies for clinical application"

Yasuto Akiyama, Chief of Immunotherapy Division, Shizuoka Cancer Center Research Institute

"Establishment of a bio-chip technology for early diagnosis and treatment of cancer"

Tadashi Matsunaga, Vice-President, Tokyo Agricultural University

A system is in place for trial products resulting from the research described above in which medical technicians at Shizuoka Cancer Center will, looking at numerous patients and in a short period of time and in an ethically correct manner, evaluate and request necessary improvements from the developers before they become final products. Thus, for any study, products bringing major changes to global health care can be expected to be completed within three to five years.